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developed before 1994, and it reflected the more conser-
vative approach to the care of this patient population on
our service, as well as on many other busy vascular surgi-
cal services, at that time. In fact, in a recent study of near-
ly 10,000 elective CEA procedures performed in
Maryland from 1990 through 1995, the mean hospital
length ofstay was 4.6 days-3.6 days in 1995.1 Clearly, we
have learned from this initial experience and have signifi-
cantly revised our CEA pathway. Currently we perform all
diagnostic procedures in the outpatient setting, use the
intensive care unit selectively after operation, and have tar-
geted discharge on the first postoperative day, similar to
Dr. Calligaro's approach.
Finally, Dr. Calligaro correctly emphasized that all
patients who undergo CEA in a tertiary care hospital may
not fit the profile of the ideal CEA critical pathway patient.
The CEA patient population at the Johns Hopkins
Hospital is the oldest in the state.1 Previous work from
our institution demonstrated that elderly patients may
undergo CEA without increased operative risk, although
they do incur a longer hospital length of stay.2 This obser-
vation has recently been confirmed in our statewide analy-
sis.1 Our critical pathway study was a methodologic analy-
sis that demonstrated that proper control patient popula-
tions must be identified to fully assess the appropriate role
and impact of critical pathways in the delivery of patient
care. In that regard, we appreciate Dr. Calligaro's support
and would urge our vascular surgical colleagues to be cau-
tious in not "pushing the envelope" too far in attempting
to meet the expectations of the third-party payers.
Bruce A. Perler, MD
Alan Dardik, MD, PhD
Department of Surgery
Johns Hopkins Hospital
600 N. Wolfe St., Blalock 685
Baltimore, MD 21257-4685
REFERENCES
1. Peder BA, Dardik A, Budeyson GP, Gordon TA, Williams
GM. Influence of age and hospital volume on the results of
carotid endarterectomy: a statewide anlaysis of 9918 cases. J
Vasc Surg 1998;27:25-33.
2. Peder BA. The impact of advanced age on the results of
carotid endarterectomy: an outcome analysis. J Am Coll Surg
1996;183:559-64.
24/41/86250
Does increased diameter of vascular prostheses really
enhance patency rates?
To the Editors:
I read with interest the article by Abbott and col-
leagues that appeared in the Journal of Vascular Sur,qery
earlier this year ("Prosthetic above-knee femoropopliteal
bypass grafting: Results of a multicenter randomized
prospective trial." J Vasc Sueg 1997;25:19-28). The
authors compared Dacron and polytetrafluoroethylene
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grafts for above-knee femoropopliteal bypass grafting in a
multicenter randomized prospective trial and did not find
significant differences. From their multivariate analysis,
they also conclude that peripheral nonautologous vascular
grafts are less prone to occlusion if the diameter is large,
that is, 7 to 8 mm rather than 5 to 6 mm.
Although it seems difficult to argue against the results
of a multivariate analysis, I am concerned about the latter
conclusion and I would like to question it on the grounds
ofan in vivo experimental study that we published in 19811
and also on the grounds of theoretical considerations.
Many years ago, some authors recommended that the
diameter of the prosthesis should exceed that of the recip-
ient vessel by as much as 50%.2 We addressed this question
in a controlled experimental in vivo study.1 In 14 beagle
dogs with aortic diameters between 6 and 9 mm, the
infrarenal aorta was replaced by polytetrafluoroethylene
grafts. Grafts 30 mm in length and with diameters of 6 or
8 mm were assigned at random, irrespective of the diame-
ter of the aorta. As a consequence, graft diameters were
greater than that of the aorta in six dogs, smaller in six
dogs, and identical in two dogs. After 6 months, the ani-
mals were killed and an autopsy was performed. Of the six
grafts that were wider than the aorta, four were complete-
ly occluded and one was partially occluded. All other
grafts were patent. There was a significant difference in
favor of grafts that had a diameter equal to that of the
aorta or smaller (p < 0.01). We assumed that the poor per-
formance of wider grafts was a result of a decrease in flow
velocity. Low flow has been recognized as a factor that
encourages thrombus formation and as a critical factor in
graft patency for a long time.
On the other hand, why should an increased graft
diameter enhance patency rates? One might speculate that
its lumen will inevitably be narrowed by layers of clot over
time, and if the lumen is wider in the first place it might
take longer until total occlusion occurs. However, our
results point into a different direction-wider grafts
encourage the beginning of thrombus formation. Once
the lumen is reduced to "normal," thrombus formation
continues because the surface is now more thrombogenic
than that of the original graft.
But then how could we explain the results of the actu-
al multicenter trial, which are in favor of larger grafts?
Most practitioners will be prone to use smaller diameters
if the outflow vessels are small, calcified, or otherwise dis-
eased. Therefore, the extremities treated by larger pros-
theses may represent a positive selection. I take it that
some surgeons who used larger diameters by principle had
better results than the average. If this is so, I have a strong
suspicion that these surgeons operated more frequently on
patients in whom larger grafts were indicated, that is, on
positively selected patients.
I believe that the question of graft diameter is an
important one and that it deserves interest. Because of a
near total absence ofmeaningful studies, further investiga-
tion is warranted. In my opinion, a recommendation to
use larger grafts in lower extremity prosthetic bypass pro-
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cedures is premature and might lead to an additional
threat to many extremities.
Markus A. Enzler, MD
Gefasschirurg EBSQ, Chirurg FMH
GefassZentrum Hirslanden
Witellikerstrasse 40
8029 Zurich, Switzerland
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Reply
10 the Editors:
I am grateful to Dr. Enzler for calling our attention to
his interesting work ofnearly two decades ago. It has long
been my belief, along with that of Dr. Enzler, that higher
flow velocities in small-diameter prostheses would yield
better results. His work, ofwhich I was not aware, strong-
ly shows that.
On the other hand, Dr. Enzler questions the results of
the multicenter randomized study. Although puzzling, the
fact is that the data are the data. Cox proportional hazards
regression analysis shows that the patency rate in larger-
diameter (7 to 8 mm) grafts (hazards ratio, 4.15) is supe-
rior to that in smaller-caliber grafts (5 to 6 mm). Dr.
Enzler should also read carefully what we said about it in
the paper. Most patients who undergo these short above-
knee reconstructions have fairly good-sized arteries, so the
size mismatch may not be actually as great as one would
suppose. And like Dr. Enzler, I usually size the graft
roughly to the size of the distal artery. The study group is
continuing to look at this interesting finding. But for the
moment, the data about graft size pertains to the final
statement in the abstract: "graft size should be carefully
considered in patients who undergo this operation."
William M. Abbott, MD
Department ofVascular Surgery
Massachusetts General Hospital
15 Parkman St., WAC 458
Boston, MA 02114
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Regarding "Thrombolysis of occluded infrainguinal
vein grafts: Predictors of outcome"
To the Editors:
I was pleased to read the recent report by Nackman and
colleagues on thrombolysis of occluded infrainguinal vein
grafts (J Vasc Surg 1997;25:1023-32), which demonstrated
the importance ofgraft age (>12 months) in selecting grafts
that would have a superior 2-year patency rate after lysis.
The similarity oftheir format and results to the paper I pre-
sented at the 1995 meeting of the Society for Clinical
Vascular Surgery and published in the American Journal of
Sut;gery1 is striking, but apparently it was never reviewed by
the authors nor referenced in their bibliography.
Their criticism ofprior publications because of insuffi-
cient follow-up and failure to independently analyze
results of different graft materials is generally valid.
However, our report of 61 thrombosed infrainguinal
bypass grafts included 48 vein grafts (36 saphenous, 12
alternative), which were analyzed separately and had a 26%
5-year secondary patency rate. We demonstrated that graft
age greater than 10 months had a very significant effect in
improving late patency rates by univariate and multivariate
analysis. The relative risk of occlusion for grafts less than
10 months old was 1.58 (p < 0.047), similar to the results
in the present report of 2.4 (p < 0.02) for grafts less than
12 months old.
Most importantly, the 5-year secondary patency rate
of 36 saphenous vein grafts was 45% if the grafts were
greater than 10 months old but only 21%if they were less
than 10 months old (p < 0.008), suggesting that throm-
bolytic therapy for intact saphenous vein grafts (as
opposed to alternative vein or polytetrafluoroethylene
grafts) can achieve patency rates that are competitive with
the results of secondary bypass procedures, especially if
another saphenous vein is not available. To emphasize this
point, a review of 161 secondary bypass grafts from my
own data showed 5-year secondary patency rates of 67%,
50%, and 31% for saphenous vein, alternative vein, and
polytetrafluoroethylene grafts, respectively.
Although I am disappointed that the authors over-
looked our larger and longer series that proved the same
point, I am pleased to bring this experience to the attention
of the authors and the readers of the Journal of Vascular
Sut;gery to reenforce these important observations.
Henry D. Berkowitz, MD
Allegheny University Hospitals
Broad & Vine, Mail Stop 468
Philadelphia, PA 19102-1192
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